Article

Intra-Bone Marrow Administration of Mesenchymal Stem/Stromal Cells Is a Promising Approach…

Stem Cells International · 2019 · Hideki Agata, author Yoshinori Sumita, author Tatsuro Hidaka, author Mayumi Iwatake, author Hideaki Kagami, author Izumi Asahina, author Dario Siniscalco, Academic Editor

Key facts

Title Intra-Bone Marrow Administration of Mesenchymal Stem/Stromal Cells Is a Promising Approach for Treating Osteoporosis
First author Hideki Agata, author Yoshinori Sumita, author Tatsuro Hidaka, author Mayumi Iwatake, author Hideaki Kagami, author Izumi Asahina, author Dario Siniscalco, Academic Editor
Journal Stem Cells International
Published Jul 17, 2019
DOI 10.1155/2019/4214281
Devices mentioned K011314, K080065, K081561, K140854, K162583, K800552, K853723, K860811, K862004, K874160, K874609, K912581 and 15 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, ITX, IYN, KKX and 5 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature